KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Ductal Breast Carcinoma in Situ|Skin Reactions Secondary to Radiation Therapy|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer
Interventions: PROCEDURE: dermatologic complications management/prevention|OTHER: questionnaire administration
Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)